BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

$1.25
+0.01 (+0.81%)
As of Feb 8, 2:27 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,616.8% upside
Low Target $19.62
Average Target $33.96
High Target $35.69
Current Price $1.25
Current
$1.25
Target
$33.96
$19.62 $33.96 avg $35.69
Scenario Analysis
Bear Case
$19.62
1,469.6%
Low target
Base Case
$33.96
+2,616.8%
Avg target
Bull Case
$35.69
+2,755.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$40.94
-96.9% from high
52-Week Low
$23.29
+-94.6% from low
Target vs 52W High
$33.96
-17.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%